About your Search

20110701
20110731
Search Results 0 to 2 of about 3
-smoking drug to heart problems. dr. jon lapook examines the study and what it means. mandy clark one on one with the top u.s. commander in afghanistan on the future of the war and the decision to begin pulling out. the man accused of the worst war crimes in europe since the nazis shows nothing but contempt for justice. mark phillips has the pictures from the court. and on this fourth of july as the space shuttle program nears an end, jim axelrod asks "what happened to the flags on the moon?" >> it's beautiful. >> pelley: do those star spangled banners yet wave? captioning sponsored by cbs this is the "cbs evening news" with scott pelley. >> pelley: good evening, chantix is the most popular anti-smoking drug on the market with annual sales of nearly $800 million. but a study out today raises new safety questions about it. chantix has already been linked to an increased risk of suicidal thoughts and now to a higher risk of heart disease. we asked dr. jon lapook to tell us what we need to know about these new findings. >> reporter: today's study is worrisome news for the more than seven millio
. dr. jon lapook has more. >> reporter: worrisome news for the more than 7 million americans who have taken chantix. a new analysis links the pill to a 72% increase in the risk of heart problems. johns hopkins dr. singh led the research. >> it is causing the same problems that we are trying to prevent, that's why it's not worth the risk. we need to prevent cardio disease among smokers, not increase. >> reporter: the review combines 14 studies involving more than 8,000 patients. while a 72% increased risk sounds alarming, the companion editorial titles, is it a heartbreaker? notes that cardiovascular problems including chest pain, heart attack and stroke are still rare. occurring in only about 1% of patients taking chantix. the drugmaker pfizer questions the way the analysis was conducted. dr. gail caldwell is vice president of medical affairs for pfizer. >> we will continue to do a more in-depth look as the fda is asking us to do but to date we have not seen evidence of important risks to the heart health of patients. from chantix. >> reporter: in mid june the fda warned chantix might
was former utah governor jon huntsman, the most moderate of the candidates vying for the anti-romney vote. huntsman has already ruled out competing in iowa and understands new hampshire is a must-win state. >> it is absolutely central to victory. this is a state you must win. >> reporter: in iowa, which votes first in a presidential contest, candidates were fighting for the social conservative vote. there were long shots newt gingrich and rick santorum. as well as tea party sensation michele bachmann. a recent poll has the minnesota congresswoman in a statistical dead heat with romney while gingrich and santorum barely made a dent in the single digits. tim pawlenty also polled poorly there. he raised a disappointing $4.2 million this quarter and has had no public event over the holiday weekend. but those in the bottom half of the poll can take comfort in the fact that the early polls don't tell us that much. this time four years ago mike huckabee was way down at 4% right where rick santorum is today. huckabee ended up winning iowa. >> jan crawford in washington this morning, thanks. >>> j
Search Results 0 to 2 of about 3